The traditional Chinese medicine Fuzi improves lipid metabolism disorders in mice with Yang deficiency and hyperlipidaemia by modulating the PKA – PPARα–carnitine palmitoyltransferase 1α (CPT1α) pathway. Here, CPT1A is linked to yang deficiency.